Skip to main content

Table 1 Summary of the data source used for non-interventional observational studies conducted in Japan

From: Characterization and selection of Japanese electronic health record databases used as data sources for non-interventional observational studies

Study type

Data source

Database example

Strengths

Limitations

Single-center study

Data stored at a single medical institution

-

Medical practice well-known

Flexible approach

Limited volume of data [28]

Multi-center study

Medical records collected from collaborating medical institutions

-

Study team collaboration

Selection bias [29, 30]

Medical practices can differ by institution [30]

Post-marketing surveillance studya

Medical records collected from participating medical institutions

-

Data volume

Cost [31]

Study using a disease registry/database

Disease registry

Disease database

All Japan Utstein Registry [22, 23]

NinJa [24, 25]

KCHF Registry [26, 27]

Disease-specific test results available

Data volume

Selection bias [27]

Study using a dataset from a large-scale integrated database

Integrated large-scale database

JMDC Claimb

MDV Databasec

NDB Japand

MID-NETe

Data volume

Careful interpretation of data is needed [31]

  1. PMS Post-marketing surveillance, GPSP Good Post-marketing Study Practice, NinJa National Database of Rheumatic Diseases by iR-net (Divison of Rheumatology, Immunologic Disorder Network, National Hospital Organization) in Japan, KCHF Registry Kyoto Congestive Heart Failure Registry, JMDC Japan Medical Data Center, MDV Medical Data Vision, NDB Japan National Database of Health Insurance Claims and Specific Health Checkups of Japan, MID-NET Medical Information Database Network
  2. aA PMS study is a kind of multi-center study initiated by a sponsor and conducted under GPSP regulations [14, 15]
  3. bJMDC Claim is provided by Japan Medical Data Center, Inc. [17]
  4. cMDV Database is provided by Medical Data Vision Co., Ltd. [18]
  5. dNDB Japan is provided by the Ministry of Health, Labour and Welfare of Japan [19, 20]
  6. eMID-NET is sponsored by the Pharmaceuticals and Medical Devices Agency of Japan [21]